Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Solventum · Product launch · October 19, 2026

Solventum received FDA 510(k) clearance to use its Restrata Synthetic Electrospun Fiber Matrix together with V.A.C. Therapy.

Read the announcement

AntSpace’s summary of Solventum’s own announcement: read the original.

More updates from Solventum